OPRX - OptimizeRx Corporation
| Previous Close | 13.51 |
| Open | 13.53 |
| Bid | 13.54 x 2200 |
| Ask | 13.99 x 800 |
| Day's Range | 13.48 - 14.14 |
| 52 Week Range | 8.92 - 18.00 |
| Volume | 2,058 |
| Avg. Volume | 97,130 |
| Market Cap | 188.832M |
| Beta (3Y Monthly) | 0.10 |
| PE Ratio (TTM) | 333.66 |
| EPS (TTM) | 0.04 |
| Earnings Date | May 11, 2017 - May 12, 2017 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 25.33 |
- GlobeNewswire
OptimizeRx Sets Third Quarter 2019 Conference Call for Tuesday, November 5, 2019 at 4:30 p.m. ET
ROCHESTER, Mich., Oct. 22, 2019 -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health solutions for payers, medtech companies, medical associations and the.
- GlobeNewswire
OptimizeRx Sponsors WOMEN at HLTH Program at the 2019 HLTH Conference
OptimizeRx Corp. (OPRX), a leading platform for digital health messaging in the pharmaceutical industry, is sponsoring the WOMEN at HLTH program at HLTH 2019, the nation’s largest conference focused on health innovation. HLTH is a one-of-a-kind ecosystem event for the health industry, bringing together more than 5,000 senior leaders to address the most pressing problems facing healthcare today. WOMEN at HLTH is a series of activities at HLTH focused on advancing and empowering women.
- Thomson Reuters StreetEvents
Edited Transcript of OPRX earnings conference call or presentation 7-Aug-19 8:30pm GMT
Q2 2019 OPTIMIZERx Corp Earnings Call
- GlobeNewswire
OptimizeRx Signs Exclusive Agreement with NewCrop to Offer Digital Health Messages and Create a Health Tech Innovation Lab for Life Sciences
OptimizeRx Corp. (OPRX), a leading provider of digital health solutions for payers, medtech companies, medical associations and the pharmaceutical industry, has secured a three-year exclusive partnership with NewCrop, a provider of integrated electronic prescribing software, to deliver real-time digital health messages to NewCrop’s e-prescribing network of more than 65,000 healthcare professionals. The agreement builds upon a long standing, profitable relationship between the two partners, and solidifies OptimizeRx as the largest digital platform connecting life sciences to the point-of-care.
- GlobeNewswire
OptimizeRx Invited to Host Plenary Sessions at Digital Pharma East on September 17-20, 2019
OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, will host two plenary sessions at the 13th Annual Digital Pharma East conference being held at the Pennsylvania Convention Center in Philadelphia on September 17-20, 2019. Bringing together more than 1,000 participants, this conference will feature latest case studies and senior-level discussions with pharma companies, health systems, physicians, health-tech companies, startups and non-traditional healthcare companies involved in digital health. The first plenary session, “Success in Today’s Evolving Pharma Marketing Landscape,” will be hosted by Steve Silvestro, chief commercial officer of OptimizeRx, at 11:00 a.m. Eastern time on September 17.
- Zacks
Zacks.com featured highlights include: Digital Turbine, Perion, Controladora Vuela, OptimizeRx and Eldorado Gold
Zacks.com featured highlights include: Digital Turbine, Perion, Controladora Vuela, OptimizeRx and Eldorado Gold
- Zacks
5 Breakout Stocks for Explosive Returns
This method involved zeroing in on those stocks whose prices are varying within a narrow band.
- GlobeNewswire
OptimizeRx to Acquire Digital Therapeutics SaaS Platform Provider, RMDY Health
OptimizeRx Corp. (OPRX) to acquire RMDY Health, a multipurpose digital therapeutics SaaS platform, for $16 million in cash and equity. The RMDY Health platform is used by pharma, payers, MedTech companies and medical associations nationwide.
- Simply Wall St.
Should You Be Holding OptimizeRx Corporation (NASDAQ:OPRX)?
Building up an investment case requires looking at a stock holistically. Today I've chosen to put the spotlight on...
- GlobeNewswire
OptimizeRx to Participate at Lake Street Annual Best Ideas Growth Conference on September 12, 2019
OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to participate in the Lake Street Capital Markets 3rd Annual Best Ideas Growth (BIG3) Conference being held on September 12, 2019 at the Parker New York. The company’s digital health network is expanding into the acute care market after reaching more than half of the ambulatory patient market in the U.S. The event is for institutional clients of Lake Street and is by invitation only.
- Simply Wall St.
Imagine Holding OptimizeRx (NASDAQ:OPRX) Shares While The Price Zoomed 331% Higher
Generally speaking, investors are inspired to be stock pickers by the potential to find the big winners. You won't get...
- GlobeNewswire
OptimizeRx Reports Record Second Quarter 2019 Results; Total Revenue Up 37% to $7.0 Million, Net Income up 45% to $407,000 or $0.03 per Diluted Share
ROCHESTER, Mich., Aug. 07, 2019 -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the.
- Zacks
Has OptimizeRx (OPRX) Outpaced Other Computer and Technology Stocks This Year?
Is (OPRX) Outperforming Other Computer and Technology Stocks This Year?
- Zacks
OptimizeRx (OPRX) to Report Q2 Earnings: What's in Store?
OptimizeRx's (OPRX) second-quarter 2019 results are likely to benefit from increased sales of core financial and brand messaging products.
- Zacks
OptimizeRx (OPRX) Gains As Market Dips: What You Should Know
OptimizeRx (OPRX) closed the most recent trading day at $15.09, moving +0.8% from the previous trading session.
- Zacks
OptimizeRx (OPRX) Reports Next Week: Wall Street Expects Earnings Growth
OptimizeRx (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
OptimizeRx (OPRX) Dips More Than Broader Markets: What You Should Know
In the latest trading session, OptimizeRx (OPRX) closed at $15.11, marking a -0.66% move from the previous day.
- GlobeNewswire
OptimizeRx Sets Second Quarter 2019 Conference Call for Wednesday, August 7, 2019 at 4:30 p.m. ET
ROCHESTER, Mich., July 24, 2019 -- OptimizeRx Corp. (Nasdaq: OPRX), a leading platform for digital health messaging in the pharmaceutical industry, will hold a conference call.
- GlobeNewswire
OptimizeRx Establishes Direct Partnership and Integration with NextGen Healthcare
ROCHESTER, Mich., July 23, 2019 -- OptimizeRx Corp. (Nasdaq: OPRX), a leading platform for digital health messaging in the pharmaceutical industry, announced a new partnership.
- Simply Wall St.
Could The OptimizeRx Corporation (NASDAQ:OPRX) Ownership Structure Tell Us Something Useful?
The big shareholder groups in OptimizeRx Corporation (NASDAQ:OPRX) have power over the company. Institutions often own...
- Benzinga
18 Stocks Joining The Russell Indices
The Russell 2000 Index is a small-cap stock market index that includes the bottom 2,000 companies found in the Russell 3000 index. The Russell Microcap Index includes the 1,000 smallest securities found ...
- GlobeNewswire
OptimizeRx Set to Join Russell Microcap® and 3000® Indexes
OptimizeRx Corp. (OPRX), a leading platform for digital health messaging in the pharmaceutical industry, is expected to join the Russell Microcap® and 3000® Indexes at the conclusion of the 2019 Russell indexes annual reconstitution, effective after the U.S. market opens on July 1, according to a preliminary list of additions posted June 21. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. “We are honored to be included in the Russell Indexes,” said OptimizeRx CEO, William Febbo.
